As the world’s population expands and ages, the demand for medicines will require higher levels of automation and product integrity. 

NovaTech works with Merck, Abbott Labs, DSM Pharmaceuticals, and BASF to help provide life savings products including cancer fighting agents and intravenous drugs to address chronic diseases, autoimmune disorders, and infections.  NovaTech products support the production of sterile products including H1N1 flu vaccine, over-the-counter solid dose medications, topical ointments, and biologics, all in accordance with stringent 21 CFR Part 11 and GAMP 5 standards (this last a requirement for the D/3’s selection as the platform of choice for a large pharmaceutical manufacturing facility in France).